Hyperbaric Oxygen Therapy in the Management of Zygomatic Bone Osteomyelitis. | Canada Hyperbarics Skip to main content
Review Journal of maxillofacial and oral surgery 2021

Hyperbaric Oxygen Therapy in the Management of Zygomatic Bone Osteomyelitis.

Monis PL, Bhat V, Shetty S, Salins PC — Journal of maxillofacial and oral surgery, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated the use of hyperbaric oxygen therapy (HBOT) in a patient with zygomatic bone osteomyelitis to preserve the bone and promote revascularization.

What They Found

After 30 sessions of hyperbaric oxygen therapy, CT scans revealed partial reconstitution of cortical bone and minimal residual sequestra. This allowed the patient to undergo conservative sequestrectomy instead of extensive surgery.

What This Means for Canadian Patients

For Canadian patients with zygomatic bone osteomyelitis, hyperbaric oxygen therapy may offer a less invasive treatment option. This approach could potentially help preserve facial bone structure and reduce the need for extensive reconstructive surgery.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a single case report, the findings of this study cannot be generalized to a larger patient population.

Was this summary helpful?

Study Details

Study Type Review
Category Wound Care
Source Pubmed
PubMed ID 34408368
Year Published 2021
Journal Journal of maxillofacial and oral surgery

Cite This Study

Share

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.